Exogene

Exogene is a biotechnology startup accelerating the discovery of T-cell-receptor(TCR)-based cell therapies for otherwise untreatable solid tumors. They are building a machine learning platform to comprehensively screen TCRs from tumor-infiltrating lymphocytes (TILs) derived from cancer patients to rapidly find new canc

Exogene is a business in health.

Profile

Exogene is a biotechnology startup accelerating the discovery of T-cell-receptor(TCR)-based cell therapies for otherwise untreatable solid tumors. They are building a machine learning platform to comprehensively screen TCRs from tumor-infiltrating lymphocytes (TILs) derived from cancer patients to rapidly find new cancer targets and target-specific TCRs for therapeutic application. Using novel wet-lab TCR screening technologies (yeast […]

The company sits in the health segment, where it competes on its core product or service.

Its current recorded stage is Creative Destruction Lab alumni company.

Website: exogene.co.uk